Disclosures for "Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: Results of the ISTRA ADJUST PD Randomized, Controlled Study")
-
Taku Hatano, MD, PhD has nothing to disclose.
-
Dr. Kano has nothing to disclose.
-
Dr. Sengoku has nothing to disclose.
-
Mr. Yanagisawa has nothing to disclose.
-
Prof. Nagayama has nothing to disclose.